177 related articles for article (PubMed ID: 35267967)
1. Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial.
Sainz T; Diaz L; Rojo D; Clemente MI; Barbas C; Gosalbes MJ; Jimenez-Hernandez N; Escosa L; Guillen S; Ramos JT; Muñoz-Fernández MÁ; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267967
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study.
Sainz T; Gosalbes MJ; Talavera-Rodríguez A; Jimenez-Hernandez N; Prieto L; Escosa L; Guillén S; Ramos JT; Muñoz-Fernández MÁ; Moya A; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708743
[TBL] [Abstract][Full Text] [Related]
3. Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial.
Sainz T; Casas I; González-Esguevillas M; Escosa-Garcia L; Muñoz-Fernández MÁ; Prieto L; Gosalbes MJ; Jiménez-Hernández N; Ramos JT; Navarro ML; Mellado MJ; Serrano-Villar S; Calvo C
Front Pediatr; 2022; 10():919753. PubMed ID: 35928688
[TBL] [Abstract][Full Text] [Related]
4. Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance.
Munjoma PT; Chandiwana P; Wyss J; Mazhandu AJ; Jordi SBU; Gutsire R; Katsidzira L; Yilmaz B; Misselwitz B; Duri K
Front Immunol; 2023; 14():1280262. PubMed ID: 38045684
[TBL] [Abstract][Full Text] [Related]
5. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1.
Missailidis C; Sørensen N; Ashenafi S; Amogne W; Kassa E; Bekele A; Getachew M; Gebreselassie N; Aseffa A; Aderaye G; Andersson J; Brighenti S; Bergman P
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31330899
[TBL] [Abstract][Full Text] [Related]
7. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
Sessa L; Reddel S; Manno E; Quagliariello A; Cotugno N; Del Chierico F; Amodio D; Capponi C; Leone F; Bernardi S; Rossi P; Putignani L; Palma P
AIDS; 2019 May; 33(6):1001-1011. PubMed ID: 30946154
[TBL] [Abstract][Full Text] [Related]
8. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
Serrano-Villar S; Vázquez-Castellanos JF; Vallejo A; Latorre A; Sainz T; Ferrando-Martínez S; Rojo D; Martínez-Botas J; Del Romero J; Madrid N; Leal M; Mosele JI; Motilva MJ; Barbas C; Ferrer M; Moya A; Moreno S; Gosalbes MJ; Estrada V
Mucosal Immunol; 2017 Sep; 10(5):1279-1293. PubMed ID: 28000678
[TBL] [Abstract][Full Text] [Related]
9. Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).
Serrano-Villar S; de Lagarde M; Vázquez-Castellanos J; Vallejo A; Bernadino JI; Madrid N; Matarranz M; Díaz-Santiago A; Gutiérrez C; Cabello A; Villar-García J; Blanco JR; Bisbal O; Sainz T; Moya A; Moreno S; Gosalbes MJ; Estrada V
Clin Infect Dis; 2019 Jan; 68(1):120-130. PubMed ID: 29788075
[TBL] [Abstract][Full Text] [Related]
10. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
[TBL] [Abstract][Full Text] [Related]
11. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
12. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
[TBL] [Abstract][Full Text] [Related]
13. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.
Vujkovic-Cvijin I; Dunham RM; Iwai S; Maher MC; Albright RG; Broadhurst MJ; Hernandez RD; Lederman MM; Huang Y; Somsouk M; Deeks SG; Hunt PW; Lynch SV; McCune JM
Sci Transl Med; 2013 Jul; 5(193):193ra91. PubMed ID: 23843452
[TBL] [Abstract][Full Text] [Related]
15. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
16. Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.
Arnbjerg CJ; Vestad B; Hov JR; Pedersen KK; Jespersen S; Johannesen HH; Holm K; Halvorsen B; Fallentin E; Hansen AE; Lange T; Kjær A; Trøseid M; Fischer BM; Nielsen SD
J Acquir Immune Defic Syndr; 2018 Aug; 78(4):450-457. PubMed ID: 29874201
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study.
Serrano-Villar S; Talavera-Rodríguez A; Gosalbes MJ; Madrid N; Pérez-Molina JA; Elliott RJ; Navia B; Lanza VF; Vallejo A; Osman M; Dronda F; Budree S; Zamora J; Gutiérrez C; Manzano M; Vivancos MJ; Ron R; Martínez-Sanz J; Herrera S; Ansa U; Moya A; Moreno S
Nat Commun; 2021 Feb; 12(1):1139. PubMed ID: 33602945
[TBL] [Abstract][Full Text] [Related]
18. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy.
Kaur US; Shet A; Rajnala N; Gopalan BP; Moar P; D H; Singh BP; Chaturvedi R; Tandon R
Sci Rep; 2018 Dec; 8(1):17679. PubMed ID: 30518941
[TBL] [Abstract][Full Text] [Related]
19. Characterization of gut microbiota composition in HIV-infected patients with metabolic syndrome.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Physiol Biochem; 2019 Aug; 75(3):299-309. PubMed ID: 30924020
[TBL] [Abstract][Full Text] [Related]
20. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.
Xie Y; Sun J; Wei L; Jiang H; Hu C; Yang J; Huang Y; Ruan B; Zhu B
BMC Microbiol; 2021 Jan; 21(1):11. PubMed ID: 33407128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
